Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [111In]-labeled CHX-A"DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines
Fingerprint
Dive into the research topics of 'Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [<sup>111</sup>In]-labeled CHX-A"DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines'. Together they form a unique fingerprint.